I am very pleased to introduce Ernest Beutler and to provide an overview of the breadth and depth of his contributions to medicine. Ernie is among a very small number of physicianscientists who over five decades during the 20th century has made notable contributions to the understanding of a remarkable range of human diseases. These include over 800 scientific or medical papers, as well as numerous chapters, books, and monographs. Indeed, it is hard to find an aspect of hematology on which Ernie's fingerprints, perhaps more aptly his DNA, cannot be detected. I used the 'Combine' function of Medline and virtually every major term in hematology coupled with Beutler resulted in significant papers.
Ernie's professional life can be entitled a tale of three cities: Chicago, Duarte and La Jolla. After graduating with honors from the University of Chicago, its medical school, and its residency program, Ernie entered the US Army Medical Corps. The Korean War resulted in the pressing need to develop better prophylaxis and treatment of malaria. Ernie was assigned to the Malaria Research Project where he worked with Ray Dern and Alf Alving conducting a classic series of experiments at the Statesville Penitentiary on the pathogenesis of the hemolytic anemia in genetically susceptible individuals exposed to the antimalarial primaquine. 1 This experience resulted in a life-long interest in the biochemistry, genetics, and clinical features of glucose-6-phosphate dehydrogenase deficiency, the biochemical abnormalities underlying acquired and inherited disorders of the red cell, and the metabolic factors that enhance blood cell storage. Ernie's research contributed important findings to these areas, including very useful diagnostic assays, such as the glutathione-stability test.
2 He published comprehensive monographs to supplement his extensive original publications on red cells and their diseases, which included methods to study red cell enzymatic and metabolic disorders. 3 After serving in the Army, he joined the faculty at the University of Chicago. His special interests had broadened to include iron metabolism, iron deficiency, and iron overload, which, like his interest in the red cell, has led to a long record of contributions in the field that continues today.
Although thriving in Chicago, he was low in the pecking order, resources trickled down, and the expansion of his research program was improbable in the near-term. The City of Hope in Duarte, California was looking for a person to chair the division of medicine and the opportunity to acquire more space and resources was offered to him. A visit convinced him that there were talented scientists in-house and that leaving the classic university-based academic environment would not impair his research programs. Ernie's evaluation of this opportunity was correct. His scientific contributions accelerated, broadened, and deepened. Although his interests were Correspondence: MA Lichtman Received 18 November 2000; accepted 19 November 2000 diverse, unlike the proverbial jack-of-all-trades, Ernie was master of all. One cannot capture the full breadth of the over 300 papers he published with his colleagues and students during the 19 years Ernie was at City of Hope. While there he published the first formal evidence for the functional importance of X chromosome inactivation in the human female. 4 He showed that the pattern of glucose-6-phosphate dehydrogenase activity in the red cells of a woman heterozygous for the enzyme deficiency was mosaic: half the cells had normal enzyme activity and half the cells had profoundly deficient activity. This important report resulted in the application of this technique to determine the clonal origin of tumors and to distinguish neoplastic from non-neoplastic tissue changes. This derivative work of others permitted a laboratory test for and definition of neoplasia, an elusive but vital goal of cancer biologists. It also marked a point at which Ernie's interest in genetics intensified. Taking advantage of the fact that the enzyme deficiency that causes galactosemia is expressed in red cells, Ernie developed a test that has been used to screen potential carriers and newborns for the disease. He discovered a prevalent enzyme variant that he dubbed the Duarte variant.
In 1970, with the increasing evidence that stem cell transplantation was going to be a useful and important modality for treating hematologic malignancies, Ernie started a marrow transplantation program at the City of Hope. He recruited Karl Blume, a research fellow studying red cell biochemistry with Ernie, to direct the program. Blume returned to Duarte from Freiburg where, with Ernie's support, a new major center in stem cell transplantation was developed. Karl Blume and Ernie published the first paper supporting the use of allogeneic marrow transplantation as a primary treatment of acute leukemia in first remission. 5 Although Ernie's years at City of Hope were very productive, circumstances had changed and the support for programs he felt were important waned. With this in mind, he looked for a new venue to pursue his research and clinical interests.
In 1978, Ernie accepted the position of Chair of the Department of Basic and Clinical Research, now the Department of Molecular and Experimental Medicine, at the Scripps Clinic and Research Foundation. Here, his research expanded further and Ernie's renown as a molecular and clinical geneticist grew. Among the notable practical accomplishments at Scripps was his role with Dennis Carson in the development and application of 2-chlorodeoxyadenosine, cladribine, for the treatment of hairy cell leukemia. 6 More recently, his commentary on the threshold for anticipatory platelet transfusion, based on his earlier work, was instrumental in encouraging a reexamination of the utility of 'prophylactic' platelet transfusion. 7 I cannot think of anyone who could puncture the balloon of medicine-by-algorithm more skillfully than Ernie. His studies of the dose of glucocerebrosidase required to treat Gaucher's disease is another example of his natural affinity for evidence-based medicine. 8 When Ernie was at City of Hope he had amassed a large array of references that he used in the preparation of papers and books. He had applied a manual card-sorting device for reclaiming references he needed, and had a programmer develop a technique that he could apply using a PDP-1140 computer to permit him to recover references by keyword or author. Indeed, he was so dependent on this database that he bought the PDP-1140 to take with him to Scripps. The programmer who managed the database left and the code was in assembly language, so Ernie decided to develop more practical software. One of Ernie's sons, Earl, was head of the software division of a firm in La Jolla and Ernie tried to get him to write the program and commercialize it. Earl had more important tasks confronting him so Ernie, after learning some basics about programming from Earl, did it himself. This was the prototype of what became known as Reference Manager. One could usually find Ernie at the Reference Manager booth at the American Society of Hematology annual meeting where Earl, having taken over the product, was educating the world about the benefits of a reference database. 9 Ernie has been recognized for his intellectual achievements throughout his career. He was elected to Phi Beta Kappa, Alpha Omega Alpha, the American Society of Clinical Investigation, the Association of American Physicians, the American Academy of Arts and Sciences, and the National Academy of Sciences. He has served as President of the American Society of Hematology.
Ernie's accomplishments have resulted in his being selected to receive numerous awards ranging from a MERIT award from NIH, the Gairdner Foundation award, to an honorary doctorate from Tel Aviv University. He has been a named lecturer at virtually every distinguished center of hematology in North America and several in Europe, and has served on the editorial board of 18 journals of hematology, molecular medicine, and nutrition sciences. He founded and nurtured the electronic version of Blood Cells, Molecules, and Diseases, which he aptly dubbed, 'The fastest journal in the West!' His expertness has been recognized and used by over 40 medical and scientific institutions and organizations for which he has acted as a consultant, including the National Research Council and the World Health Organization.
During his career, Ernie has provided an exciting, rigorous, and supportive environment for numerous students and colleagues. I have been the beneficiary of his many insights into blood cell diseases and have had the great pleasure of workLeukemia ing with him on the last four editions of Williams Hematology, of which he is the Chief Editor. His writing style and ability to express complex ideas with lucidity serves as a model for those who communicate in science. A look at the subjects of his most recent papers in 1999, now 45 years after his studies of the hemolytic effect of primaquine, highlights his remarkable reach: gamma-glutamylcysteine synthetase deficiency, hereditary hemochromatosis, treatment of progressive multiple sclerosis, Gaucher's disease, gene therapy, triosephosphate isomerase deficiency, neonatal hyperbilirubinemia, new mutations of the glucose-6-phosphate dehydrogenase gene, sulfhemoglobinemia, structure and linkage relationships of the pyruvate kinase and glucocerebrosidase genes, and more, each spawned from a mastery of the topic.
Ernie's life has been enriched at home as well as in the office. In June 2000, Ernie and his wife Bonnie celebrated their 50th wedding anniversary, taking pride in the productive and accomplished lives of their four children and their families. I look forward to Ernie's insights into the problem of acute myelogenous leukemia.
